JP2019194212A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019194212A5 JP2019194212A5 JP2019112469A JP2019112469A JP2019194212A5 JP 2019194212 A5 JP2019194212 A5 JP 2019194212A5 JP 2019112469 A JP2019112469 A JP 2019112469A JP 2019112469 A JP2019112469 A JP 2019112469A JP 2019194212 A5 JP2019194212 A5 JP 2019194212A5
- Authority
- JP
- Japan
- Prior art keywords
- ferric
- kidney disease
- ferric citrate
- chronic kidney
- organic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 17
- 229960002413 ferric citrate Drugs 0.000 claims 14
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 claims 14
- 208000020832 chronic kidney disease Diseases 0.000 claims 11
- 150000007524 organic acids Chemical class 0.000 claims 8
- 238000004090 dissolution Methods 0.000 claims 6
- 239000002244 precipitate Substances 0.000 claims 6
- 238000001631 haemodialysis Methods 0.000 claims 4
- 230000000322 hemodialysis Effects 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 230000001376 precipitating effect Effects 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 208000028208 end stage renal disease Diseases 0.000 claims 1
- 201000000523 end stage renal failure Diseases 0.000 claims 1
- 201000005991 hyperphosphatemia Diseases 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021159648A JP2022020633A (ja) | 2006-01-30 | 2021-09-29 | 慢性腎疾患の治療法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76325306P | 2006-01-30 | 2006-01-30 | |
| US60/763,253 | 2006-01-30 | ||
| PCT/US2006/032385 WO2007022435A2 (en) | 2005-08-18 | 2006-08-18 | Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| USPCT/US2006/032385 | 2006-08-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015180311A Division JP6632842B2 (ja) | 2006-01-30 | 2015-09-14 | 慢性腎疾患の治療法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021159648A Division JP2022020633A (ja) | 2006-01-30 | 2021-09-29 | 慢性腎疾患の治療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019194212A JP2019194212A (ja) | 2019-11-07 |
| JP2019194212A5 true JP2019194212A5 (https=) | 2020-02-06 |
Family
ID=39739742
Family Applications (14)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552435A Pending JP2009525277A (ja) | 2006-01-30 | 2007-01-26 | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| JP2008552431A Pending JP2009525276A (ja) | 2006-01-30 | 2007-01-26 | 慢性腎疾患の治療法 |
| JP2013142517A Pending JP2013227333A (ja) | 2006-01-30 | 2013-07-08 | 慢性腎疾患の治療法 |
| JP2013142389A Active JP6154226B2 (ja) | 2006-01-30 | 2013-07-08 | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| JP2014157464A Active JP6368186B2 (ja) | 2006-01-30 | 2014-08-01 | 慢性腎疾患の治療法 |
| JP2015180311A Active JP6632842B2 (ja) | 2006-01-30 | 2015-09-14 | 慢性腎疾患の治療法 |
| JP2016176150A Pending JP2017036289A (ja) | 2006-01-30 | 2016-09-09 | 慢性腎疾患の治療法 |
| JP2016252260A Pending JP2017095477A (ja) | 2006-01-30 | 2016-12-27 | 慢性腎疾患の治療法 |
| JP2017041248A Active JP6239169B2 (ja) | 2006-01-30 | 2017-03-06 | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| JP2018006046A Pending JP2018109001A (ja) | 2006-01-30 | 2018-01-18 | 慢性腎疾患の治療法 |
| JP2019112469A Pending JP2019194212A (ja) | 2006-01-30 | 2019-06-18 | 慢性腎疾患の治療法 |
| JP2021159648A Pending JP2022020633A (ja) | 2006-01-30 | 2021-09-29 | 慢性腎疾患の治療法 |
| JP2023015069A Pending JP2023055886A (ja) | 2006-01-30 | 2023-02-03 | 慢性腎疾患の治療法 |
| JP2024168044A Pending JP2025016448A (ja) | 2006-01-30 | 2024-09-27 | 慢性腎疾患の治療法 |
Family Applications Before (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552435A Pending JP2009525277A (ja) | 2006-01-30 | 2007-01-26 | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| JP2008552431A Pending JP2009525276A (ja) | 2006-01-30 | 2007-01-26 | 慢性腎疾患の治療法 |
| JP2013142517A Pending JP2013227333A (ja) | 2006-01-30 | 2013-07-08 | 慢性腎疾患の治療法 |
| JP2013142389A Active JP6154226B2 (ja) | 2006-01-30 | 2013-07-08 | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| JP2014157464A Active JP6368186B2 (ja) | 2006-01-30 | 2014-08-01 | 慢性腎疾患の治療法 |
| JP2015180311A Active JP6632842B2 (ja) | 2006-01-30 | 2015-09-14 | 慢性腎疾患の治療法 |
| JP2016176150A Pending JP2017036289A (ja) | 2006-01-30 | 2016-09-09 | 慢性腎疾患の治療法 |
| JP2016252260A Pending JP2017095477A (ja) | 2006-01-30 | 2016-12-27 | 慢性腎疾患の治療法 |
| JP2017041248A Active JP6239169B2 (ja) | 2006-01-30 | 2017-03-06 | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| JP2018006046A Pending JP2018109001A (ja) | 2006-01-30 | 2018-01-18 | 慢性腎疾患の治療法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021159648A Pending JP2022020633A (ja) | 2006-01-30 | 2021-09-29 | 慢性腎疾患の治療法 |
| JP2023015069A Pending JP2023055886A (ja) | 2006-01-30 | 2023-02-03 | 慢性腎疾患の治療法 |
| JP2024168044A Pending JP2025016448A (ja) | 2006-01-30 | 2024-09-27 | 慢性腎疾患の治療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (8) | US20090186939A1 (https=) |
| EP (3) | EP1978807B1 (https=) |
| JP (14) | JP2009525277A (https=) |
| CN (4) | CN101378658A (https=) |
| AU (2) | AU2007210090B2 (https=) |
| CA (2) | CA2640974C (https=) |
| DK (1) | DK1978807T3 (https=) |
| ES (2) | ES2580127T3 (https=) |
| HU (1) | HUE028029T2 (https=) |
| IL (2) | IL192545A (https=) |
| WO (2) | WO2007089571A2 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| US20220144872A1 (en) * | 2003-02-19 | 2022-05-12 | Panion & Bf Biotech Inc. | Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same |
| TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| JP2009525277A (ja) * | 2006-01-30 | 2009-07-09 | グロボアジア エルエルシー | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| US7658952B2 (en) | 2007-10-11 | 2010-02-09 | Baxter International Inc. | Dialysis solutions containing pyrophosphates |
| CN103800310A (zh) | 2008-10-27 | 2014-05-21 | 思佰益药业股份有限公司 | 以5-氨基乙酰丙酸或其衍生物、或它们的盐作为有效成分的成人病的预防、改善剂 |
| WO2011011541A1 (en) | 2009-07-21 | 2011-01-27 | Henry Trong Le | Ferric citrate dosage forms |
| US8178709B2 (en) | 2009-07-21 | 2012-05-15 | Biolink Life Sciences, Inc. | Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof |
| JP5167389B2 (ja) * | 2010-07-07 | 2013-03-21 | 日本たばこ産業株式会社 | クエン酸第二鉄を含む錠剤 |
| JP2012112785A (ja) * | 2010-11-24 | 2012-06-14 | Tohoku Univ | 透析膜の評価方法 |
| JP2012162522A (ja) * | 2011-01-18 | 2012-08-30 | Japan Tobacco Inc | β酸化水酸化鉄を実質的に含まないクエン酸第二鉄 |
| US20130345303A1 (en) * | 2012-06-21 | 2013-12-26 | Keryx Biopharmaceuticals, Inc. | Use of ferric citrate in the treatment of chronic kidney disease patients |
| US9539283B2 (en) * | 2012-09-04 | 2017-01-10 | The Board Of Regents Of The University Of Texas System | Citrate-rich calcium-magnesium supplement and uses thereof |
| EP3747432A1 (en) * | 2013-11-04 | 2020-12-09 | Keryx Biopharmaceuticals, Inc. | Ferric citrate for reducing cardiac failure in chronic kidney disease patients |
| EP3157516A4 (en) * | 2014-06-22 | 2017-12-13 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| JP2018526349A (ja) * | 2015-08-05 | 2018-09-13 | ルピン・リミテッド | 医薬品グレードのクエン酸第二鉄の調製のためのプロセス |
| JP7578234B2 (ja) * | 2017-04-18 | 2024-11-06 | 国立大学法人東北大学 | アルカリ性化剤による血液浄化 |
| WO2018193648A1 (ja) * | 2017-04-18 | 2018-10-25 | 国立大学法人東北大学 | アルカリ性化剤による血液浄化 |
| JP7219898B2 (ja) * | 2017-04-18 | 2023-02-09 | 国立大学法人東北大学 | アルカリ性化剤による血液浄化 |
| IT201700085412A1 (it) * | 2017-07-26 | 2019-01-26 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
| IT201700089258A1 (it) | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
| CN112292595B (zh) | 2018-01-12 | 2024-03-08 | 梅约医学教育与研究基金会 | 用于检测和定量流体中氨和铵的系统和方法 |
| EP3823610A4 (en) * | 2018-07-17 | 2022-08-31 | The Regents of the University of California | METHODS OF TREATMENT OF KIDNEY DISEASE |
| CN113164422A (zh) * | 2018-10-17 | 2021-07-23 | 京都府公立大学法人 | 糖尿病肾病中的肾纤维化抑制剂 |
| AU2019361520B2 (en) * | 2018-10-17 | 2025-04-24 | Nippon Chemiphar Co., Ltd. | Novel pharmaceutical composition |
| CA3137691A1 (en) * | 2019-04-28 | 2020-11-05 | Tohoku University | Novel pharmaceutical composition |
| IT201900007326A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari |
| IT201900007311A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati |
| WO2021229160A1 (fr) * | 2020-05-13 | 2021-11-18 | Compagnie Generale Des Etablissements Michelin | Pneumatique a adherence sur sol mouille amelioree en fin de vie |
| AU2022227671A1 (en) * | 2021-02-24 | 2023-09-07 | MoxxiTech, LLC | Compositions and methods for treating canine parvovirus infection |
| EP4347022A1 (en) | 2021-05-27 | 2024-04-10 | Keryx Biopharmaceuticals, Inc. | Pediatric formulations of ferric citrate |
| KR102623739B1 (ko) * | 2022-07-28 | 2024-01-11 | 주식회사 페라메드 | 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2081547A (en) | 1934-02-14 | 1937-05-25 | Parke Davis & Co | Therapeutic agent |
| DE1131360B (de) | 1957-11-26 | 1962-06-14 | Vitarine Company Inc | Verfahren zum Stabilisieren von waessrigen Loesungen, die neben Vitamin B noch Vitamin B und Vitamin C enthalten |
| SU142643A1 (ru) | 1961-03-25 | 1961-11-30 | В.Б. Тихомиров | Способ извлечени соединений железа из водной фазы |
| AT279048B (de) * | 1967-07-04 | 1970-02-25 | Pharmazeutische Fabrik Montavit Gmbh | Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon |
| US3549614A (en) | 1967-07-13 | 1970-12-22 | Jan Zbigniew Mioduszewski | Method of manufacture of mixed complex compounds of ferric iron with hydrogenated dextran and citric acid or sodium citrate |
| GB1224589A (en) | 1969-10-06 | 1971-03-10 | Gerhard Gergely | Complex iron salts |
| US4180567A (en) * | 1977-09-02 | 1979-12-25 | Pharmachem Corporation | Iron preparations and methods of making and administering the same |
| DE3228231A1 (de) * | 1982-07-28 | 1984-02-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München | Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung |
| US5089644A (en) | 1985-01-04 | 1992-02-18 | Salutar Inc. | Preparation of oxamine complexes |
| US4851221A (en) | 1985-02-19 | 1989-07-25 | Mission Pharmacal Company | Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid |
| IT1222654B (it) | 1987-09-14 | 1990-09-12 | Schering Ag | Complesso micellare di ferro-citrato |
| GB2212396A (en) | 1987-12-18 | 1989-07-26 | Procter & Gamble | Dietary supplement comprising calcium and delayed release coated iron |
| US5602116A (en) * | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
| NL194959C (nl) | 1988-10-04 | 2003-09-02 | Otsuka Pharma Co Ltd | Preparaat voor het toedienen van ijzer. |
| DE69019512T2 (de) * | 1989-02-17 | 1996-02-15 | Baxter Int | Verhinderung von verkalkung in bioprosthetischen implantaten. |
| US4970079A (en) * | 1989-06-05 | 1990-11-13 | Purdue Research Foundation | Method and composition of oxy-iron compounds for treatment of hyperphosphatemia |
| JP2523057B2 (ja) | 1990-10-31 | 1996-08-07 | 有限会社丸吉商事 | 多重ポリ袋の製造方法及び製造装置 |
| DE4239442C2 (de) | 1992-11-24 | 2001-09-13 | Sebo Gmbh | Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten |
| JP3302178B2 (ja) | 1994-06-22 | 2002-07-15 | 日本クラウンコルク株式会社 | 合成樹脂製容器蓋 |
| JPH08198760A (ja) | 1995-01-20 | 1996-08-06 | Japan Organo Co Ltd | 経口用リン酸イオン吸着剤 |
| US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
| DE19638044A1 (de) | 1996-09-18 | 1998-03-19 | Bayer Ag | Immunogene Peptide von Maul- und Klauenseuchen-Viren |
| US5753706A (en) | 1996-12-16 | 1998-05-19 | Hsu; Chen Hsing | Methods for treating renal failure |
| RU2188033C2 (ru) | 1997-03-18 | 2002-08-27 | Рош Диагностикс Гмбх | Комбинированные фармацевтические препараты, содержащие эритропоэтин и препараты железа |
| US6254635B1 (en) * | 1998-02-02 | 2001-07-03 | St. Jude Medical, Inc. | Calcification-resistant medical articles |
| US6706287B2 (en) * | 2001-05-15 | 2004-03-16 | Kibow Biotech Inc. | Prebiotic and probiotic compositions and methods for their use in gut-based therapies |
| CN1315174A (zh) | 2000-03-31 | 2001-10-03 | 苏荣仁 | 治疗肾衰的药物组合物 |
| US6887897B2 (en) * | 2001-07-31 | 2005-05-03 | Mission Pharmacal Company | Calcium glutarate supplement and phosphorus binder |
| EP1539744A4 (en) | 2002-07-11 | 2007-06-06 | Vicuron Pharm Inc | N-HYDROXYAMIDE DERIVATIVES WITH ANTIBACTERIAL EFFECT |
| CN1202067C (zh) * | 2002-09-09 | 2005-05-18 | 苏荣仁 | 药用级枸橼酸铁的制备方法 |
| US8093423B2 (en) * | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| TWI335218B (en) * | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| KR100511227B1 (ko) | 2003-06-27 | 2005-08-31 | 박상래 | 휴대용 감시 카메라 및 이를 이용한 개인 방범 시스템 |
| TWI259772B (en) | 2003-09-04 | 2006-08-11 | Panion & Bf Biotech Inc | Medical composition comprising ferric citrate, ferric citrate in medical grade and preparation thereof, and dietary nutriment comprising ferric citrate |
| CN1600302A (zh) | 2003-09-22 | 2005-03-30 | 宝龄富锦生技股份有限公司 | 含有柠檬酸铁的医药组合物以及药用级柠檬酸铁及其制法和含有药用级柠檬酸铁的膳食营养品 |
| US6903235B2 (en) * | 2003-10-08 | 2005-06-07 | Panion & Bf Biotech Inc. | Pharmaceutical-grade ferric citrate |
| KR20070054191A (ko) * | 2004-07-27 | 2007-05-28 | 샤이어 파마세우티컬, 인크. | 란탄 하이드록시 카보네이트를 이용한 고인산증 치료 방법 |
| US7733285B2 (en) * | 2005-05-18 | 2010-06-08 | Qualcomm Incorporated | Integrated, closely spaced, high isolation, printed dipoles |
| US7904971B2 (en) * | 2005-05-19 | 2011-03-15 | Mine Safety Appliances Company | Protective padding and protective padding systems |
| CA2619591C (en) | 2005-08-18 | 2020-03-24 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| JP4692234B2 (ja) | 2005-11-10 | 2011-06-01 | ソニー株式会社 | 変調テーブル、変調装置および方法、プログラム、並びに記録媒体 |
| US7682811B2 (en) | 2006-01-27 | 2010-03-23 | University Of Massachusetts | Systems and methods for producing biofuels and related materials |
| KR20080106506A (ko) | 2006-01-30 | 2008-12-08 | 글로보아시아 엘엘씨 | 만성 신장병의 치료 방법 |
| JP2009525277A (ja) | 2006-01-30 | 2009-07-09 | グロボアジア エルエルシー | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| CN101019848B (zh) | 2006-11-17 | 2010-09-15 | 苏荣仁 | 枸橼酸铁在制备防治血管钙化的药物中的应用 |
| US8795877B2 (en) | 2007-05-31 | 2014-08-05 | Lg Chem, Ltd. | Electrical connecting member of assembling type and secondary battery pack containing the same |
| JP5526466B2 (ja) | 2007-07-17 | 2014-06-18 | 株式会社大林組 | 耐火セグメントの製造方法 |
| CN101235186B (zh) | 2008-01-03 | 2010-08-11 | 中国船舶重工集团公司第七二五研究所 | 一种无溶剂可自分层固化的环氧-有机硅组合物 |
| WO2011011541A1 (en) | 2009-07-21 | 2011-01-27 | Henry Trong Le | Ferric citrate dosage forms |
-
2007
- 2007-01-26 JP JP2008552435A patent/JP2009525277A/ja active Pending
- 2007-01-26 CN CNA2007800039902A patent/CN101378658A/zh active Pending
- 2007-01-26 CN CN201610003010.XA patent/CN105616397A/zh active Pending
- 2007-01-26 EP EP07717051.2A patent/EP1978807B1/en active Active
- 2007-01-26 CA CA2640974A patent/CA2640974C/en active Active
- 2007-01-26 HU HUE07717051A patent/HUE028029T2/en unknown
- 2007-01-26 AU AU2007210090A patent/AU2007210090B2/en active Active
- 2007-01-26 US US12/162,543 patent/US20090186939A1/en not_active Abandoned
- 2007-01-26 EP EP16161784.0A patent/EP3066923B1/en active Active
- 2007-01-26 CN CNA2007800039832A patent/CN101374416A/zh active Pending
- 2007-01-26 ES ES07717051.2T patent/ES2580127T3/es active Active
- 2007-01-26 DK DK07717051.2T patent/DK1978807T3/en active
- 2007-01-26 AU AU2007210096A patent/AU2007210096B2/en active Active
- 2007-01-26 WO PCT/US2007/002151 patent/WO2007089571A2/en not_active Ceased
- 2007-01-26 CA CA2640763A patent/CA2640763C/en not_active Expired - Fee Related
- 2007-01-26 CN CN201510276285.6A patent/CN105055446B/zh active Active
- 2007-01-26 JP JP2008552431A patent/JP2009525276A/ja active Pending
- 2007-01-26 EP EP07762833.7A patent/EP1978808B1/en not_active Not-in-force
- 2007-01-26 WO PCT/US2007/002157 patent/WO2007089577A2/en not_active Ceased
- 2007-01-26 US US12/162,558 patent/US9750715B2/en active Active
- 2007-01-26 ES ES07762833T patent/ES2699447T3/es active Active
-
2008
- 2008-06-30 IL IL192545A patent/IL192545A/en active IP Right Grant
- 2008-07-28 IL IL193099A patent/IL193099A/en not_active IP Right Cessation
-
2010
- 2010-06-22 US US12/821,081 patent/US20110060041A1/en not_active Abandoned
-
2013
- 2013-07-08 JP JP2013142517A patent/JP2013227333A/ja active Pending
- 2013-07-08 JP JP2013142389A patent/JP6154226B2/ja active Active
-
2014
- 2014-08-01 JP JP2014157464A patent/JP6368186B2/ja active Active
-
2015
- 2015-09-14 JP JP2015180311A patent/JP6632842B2/ja active Active
-
2016
- 2016-09-09 JP JP2016176150A patent/JP2017036289A/ja active Pending
- 2016-12-27 JP JP2016252260A patent/JP2017095477A/ja active Pending
-
2017
- 2017-03-06 JP JP2017041248A patent/JP6239169B2/ja active Active
- 2017-09-04 US US15/694,876 patent/US9889113B2/en not_active Expired - Fee Related
- 2017-11-16 US US15/814,767 patent/US10898459B2/en active Active
-
2018
- 2018-01-18 JP JP2018006046A patent/JP2018109001A/ja active Pending
- 2018-02-12 US US15/894,544 patent/US20180235923A1/en not_active Abandoned
-
2019
- 2019-06-18 JP JP2019112469A patent/JP2019194212A/ja active Pending
-
2021
- 2021-07-29 US US17/388,361 patent/US20220193022A1/en not_active Abandoned
- 2021-09-29 JP JP2021159648A patent/JP2022020633A/ja active Pending
-
2023
- 2023-02-03 JP JP2023015069A patent/JP2023055886A/ja active Pending
-
2024
- 2024-06-14 US US18/743,657 patent/US20250144065A1/en active Pending
- 2024-09-27 JP JP2024168044A patent/JP2025016448A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019194212A5 (https=) | ||
| JP2010270124A5 (https=) | ||
| JP2015212268A5 (https=) | ||
| JP2009533356A5 (https=) | ||
| JP2013501224A5 (https=) | ||
| ES2971959T3 (es) | Terlipresina para el tratamiento de la ascitis debida a cirrosis hepática administrada como una infusión continua | |
| RU2017114933A (ru) | Соединения и композиции для лечения или профилактики патологических состояний, связанных с избыточным отложением фибрина и/или образованием тромбов | |
| JP2021525729A5 (https=) | ||
| JP2016501066A5 (https=) | ||
| JP2016510326A5 (https=) | ||
| KR102252944B1 (ko) | 투석 조성물 | |
| JP2001520656A (ja) | 抗腫瘍剤としてのホルボールエステル類 | |
| EP2799074A1 (en) | Iron bis-glycinate chelate for use in the oral treatment of anemia in patients with celiac disease | |
| JP2020509035A5 (https=) | ||
| RU2013148539A (ru) | Алиспоривир для лечения инфекции вируса гепатита с | |
| JP2016514142A5 (https=) | ||
| CN103405438B (zh) | 曲匹地尔或其药学上可接受的盐在制备防治肺动脉高压药物中的应用 | |
| WO2013143462A1 (zh) | 一种血液置换基础液及其制备方法 | |
| WO2016139740A1 (ja) | 肝線維化改善剤 | |
| CN109106724A (zh) | 一种苹果酸碳酸氢盐体外血液透析剂 | |
| CA2638081A1 (en) | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions | |
| Yamada | Aspirin/heparin | |
| Rane | Oxymorphone abuse | |
| May et al. | 1241: RECTAL PROPRANOLOL TO CONTROL PAROXYSMAL SYMPATHETIC HYPERACTIVITY | |
| JP2015231976A (ja) | 心筋炎の予防または治療剤 |